Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-04-08

Clinical Trial Update: Trigeminal Nerve Stimulation in Treatment-resistant Generalized Anxiety Disorder: a Feasibility Study [NA]

View source ↗

Summary

A feasibility study evaluating trigeminal nerve stimulation for treatment-resistant generalized anxiety disorder. The trial is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Trigeminal nerve stimulation (TNS) device (trigeminal nerve stimulation)

Snippet

Sponsor: Dr. Rafael Freire | Conditions: Generalized Anxiety Disorder | NA | Status: RECRUITING